Suppressing aberrant GluN3A expression rescues synaptic and behavioral impairments in Huntington's disease models
Open Access
- 14 July 2013
- journal article
- research article
- Published by Springer Nature in Nature Medicine
- Vol. 19 (8) , 1030-1038
Abstract
Huntington's disease is a neurodegenerative disorder associated with glutamate receptor dysfunction. Now Isabel Pérez-Otaño and colleagues report that the HTT protein that aggregates in the brains of individuals with the disease disrupts the ability of the adaptor protein PACSIN1 to keep the glutamate receptor subunit GluN3A away from the surface of neurons. Huntington's disease is caused by an expanded polyglutamine repeat in the huntingtin protein (HTT), but the pathophysiological sequence of events that trigger synaptic failure and neuronal loss are not fully understood. Alterations in N-methyl-D-aspartate (NMDA)-type glutamate receptors (NMDARs) have been implicated. Yet, it remains unclear how the HTT mutation affects NMDAR function, and direct evidence for a causative role is missing. Here we show that mutant HTT redirects an intracellular store of juvenile NMDARs containing GluN3A subunits to the surface of striatal neurons by sequestering and disrupting the subcellular localization of the endocytic adaptor PACSIN1, which is specific for GluN3A. Overexpressing GluN3A in wild-type mouse striatum mimicked the synapse loss observed in Huntington's disease mouse models, whereas genetic deletion of GluN3A prevented synapse degeneration, ameliorated motor and cognitive decline and reduced striatal atrophy and neuronal loss in the YAC128 Huntington's disease mouse model. Furthermore, GluN3A deletion corrected the abnormally enhanced NMDAR currents, which have been linked to cell death in Huntington's disease and other neurodegenerative conditions. Our findings reveal an early pathogenic role of GluN3A dysregulation in Huntington's disease and suggest that therapies targeting GluN3A or pathogenic HTT-PACSIN1 interactions might prevent or delay disease progression.Keywords
This publication has 60 references indexed in Scilit:
- Identification of anti-inflammatory targets for Huntington's disease using a brain slice-based screening assayNeurobiology of Disease, 2011
- Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disordersNature Reviews Neuroscience, 2010
- Influence of the NR3A subunit on NMDA receptor functionsProgress in Neurobiology, 2010
- Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtinNature Medicine, 2009
- Downregulation of NR3A-Containing NMDARs Is Required for Synapse Maturation and Memory ConsolidationNeuron, 2009
- Opposing effects of polyglutamine expansion on native protein complexes contribute to SCA1Nature, 2008
- Huntington disease models and human neuropathology: similarities and differencesActa Neuropathologica, 2007
- The corticostriatal pathway in Huntington's diseaseProgress in Neurobiology, 2007
- Endocytosis and synaptic removal of NR3A-containing NMDA receptors by PACSIN1/syndapin1Nature Neuroscience, 2006
- Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal deathNature, 2004